Send to

Choose Destination
Clin Transl Oncol. 2009 Sep;11(9):564-71.

Angiogenesis and ovarian cancer.

Author information

Department of Clinical Oncology, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain.


Ovarian carcinoma is the most important cause of gynaecological cancer-related mortality in Western societies. The age at diagnosis, extent of disease (as expressed by FIGO state), success of primary surgery and the histopathological features of the tumour are important prognostic markers. The majority of patients with ovarian cancer present with advanced disease (FIGO stage III/IV) and in this group of patients the median survival is only three years. New treatment approaches are therefore required to improve outcome in this disease. Angiogenesis, the development of a neovascular blood supply, is a critical step in the propagation of malignant tumour growth and metastasis and represents a promising target. This review will focus on angiogenesis, VEGF biology and the potential value of angiogenic factors with prognostic value in ovarian cancer.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center